Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

@article{Bushnell2014GuidelinesFT,
  title={Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association},
  author={Cheryl D Bushnell and Louise D. McCullough and Issam A. Awad and Monique V. Chireau and Wende N. Fedder and Karen L. Furie and Virginia J. Howard and Judith H. Lichtman and Lynda D. Lisabeth and Ileana L. Pi{\~n}a and Mathew J Reeves and Kathryn M. Rexrode and Gustavo Saposnik and Vineeta Singh and Amytis Towfighi and Viola Vaccarino and Matthew R. Walters},
  journal={Stroke},
  year={2014},
  volume={45},
  pages={1545–1588}
}
Purpose— The aim of this statement is to summarize data on stroke risk factors that are unique to and more common in women than men and to expand on the data provided in prior stroke guidelines and cardiovascular prevention guidelines for women. This guideline focuses on the risk factors unique to women, such as reproductive factors, and those that are more common in women, including migraine with aura, obesity, metabolic syndrome, and atrial fibrillation. Methods— Writing group members were… Expand
Stroke Prevention in Women: Synopsis of the 2014 American Heart Association/American Stroke Association Guideline
TLDR
A sex-specific guideline that consolidates recommendations specific to stroke prevention in women from primary and secondary prevention guidelines and emphasizes stroke-specific issues in more detail than previously published cardiovascular prevention guidelines is developed. Expand
Bushnell et al Guidelines for Prevention of Stroke in Women 1547 Incidence Ischemic Stroke
Purpose—The aim of this statement is to summarize data on stroke risk factors that are unique to and more common in women than men and to expand on the data provided in prior stroke guidelines andExpand
Stroke in women: Where are we in 2015?
TLDR
This review of stroke burden in women, including sex-specific risk factors, concludes with the following recommendations: (1) careful follow up of pregnancy-related HTN, (2) increased attention to pre-hypertensive women to reduce their blood pressure through lifestyle changes, and (3) emphasize the importance of a healthy weight. Expand
Cardiovascular disease prevention in women: reducing the major threat to women's health.
TLDR
The 2014 Prevention of Stroke in Women Guideline highlights genderspecific risk factors for stroke associated with the complications of pregnancy, including gestational diabetes,hypertension, andpreeclampsia. Expand
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
TLDR
Evidence-based recommendations are included for the control of risk factors, interventional approaches to atherosclerotic disease of the cervicocephalic circulation, and antithrombotic treatments for preventing thrombosis and thromboembolic stroke. Expand
Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.
TLDR
Advances in these fields have improved the lives of women living with and at risk for heart disease, and the morbidity and mortality of CVD in women can be further reduced. Expand
Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists
TLDR
Significant improvement in mortality and morbidity rates in women have been seen over the past 2 decades, in part as a result of initiatives such as the American Heart Association’s (AHA) Go Red For Women movement, but gender-based inequalities continue. Expand
Stroke in Women: Recognizing Opportunities for Prevention and Treatment.
Women have long been underrepresented in cardiovascular disease research. In 1970, women comprised 9% of participants within cardiovascular trials.1 It has now been 3 decades since the landmark 1985Expand
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
TLDR
There is a pervasive lack of evidence to guide clinical decision making in older patients with cardiovascular disease, as well as a paucity of data on the impact of diagnostic and therapeutic interventions on key outcomes that are particularly important to older patients, such as quality of life, physical function, and maintenance of independence. Expand
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
TLDR
There is a pervasive lack of evidence to guide clinical decision making in older patients with cardiovascular disease, as well as a paucity of data on the impact of diagnostic and therapeutic interventions on key outcomes that are particularly important to older patients, such as quality of life, physical function, and maintenance of independence. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 557 REFERENCES
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
TLDR
Major randomized controlled clinical trials such as the Women’s Health Initiative have changed the practice of CVD prevention in women over the past decade and the investment in combating this major public health issue for women has been significant. Expand
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.
TLDR
Substantial progress has been made in the awareness, treatment, and prevention of cardiovascular disease (CVD) in women since the first women-specific clinical recommendations for the prevention of CVD were published by the AHA in 1999, but considerable challenges remain. Expand
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
TLDR
Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Expand
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
TLDR
An algorithm for diagnosis and management of patients with cerebral venous sinus thrombosis is described and evidence-based recommendations are provided for the diagnosis, management, and prevention of recurrence of cerebral venOUS thromBosis. Expand
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
  • A. Camm, P. Kirchhof, +22 authors F. Rutten
  • Medicine
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2010
Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patientExpand
Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.
TLDR
Recent trials testing the safety and efficacy of a thrombin inhibitor (dabigatran) and 2 factor Xa inhibitors (rivaroxaban and apixaban) in preventing stroke in patients with AF are reviewed, and management recommendations are revised. Expand
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
TLDR
Estimates of expected health outcomes for larger societies are included, where data exist, and the level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to pre-defined scales. Expand
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
TLDR
This guideline was developed in conjunction with the European Society of Cardiology (ESC) and aims to improve the effectiveness of care, optimize patient outcomes, and favorably affect the overall cost of care by focusing resources on the most effective strategies. Expand
Incidence and Risk Factors for Stroke in American Indians: The Strong Heart Study
TLDR
The findings suggest that blood pressure and glucose control and smoking avoidance may be important avenues for stroke prevention in this population of American Indians. Expand
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
TLDR
This updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention of future stroke among survivors of isChemic stroke or transient ischemic attack and to all clinicians who manage secondary prevention for these patients. Expand
...
1
2
3
4
5
...